{'text': 'Adding Multi-Media Materials: OTEZLA® (apremilast) – First Oral Therapy Approved by the U.S. Food and Drug Administration for the Treatment of Adults with Active Psoriatic Arthritis', 'publisher': {'href': 'https://www.businesswire.com', 'title': 'Business Wire'}, 'created_at': 'Mon, 24 Mar 2014 07:00:00 GMT', 'description': 'Adding Multi-Media Materials: OTEZLA® (apremilast) – First Oral Therapy Approved by the U.S. Food and Drug Administration for the Treatment of Adults with Active Psoriatic Arthritis  Business Wire', 'url': 'https://news.google.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?oc=5&hl=en-US&gl=US&ceid=US:en'}
